Clinical consensus regarding the importance of rapid reduction in depressive symptoms in major depressive disorder with acute suicidal ideation or behavior (MDSI)
Introduction Patients with major depressive disorder (MDD) with acute suicidal ideation or behavior (MDSI) require immediate intervention. Though oral antidepressants can be effective at reducing depressive symptoms, they can take 4–6 weeks to reach full effect. Objectives This study aimed to iden...
Main Authors: | S. Borentain, A. Nash, E. Daly, K. Joshi, M. O’Hara, Q. Zhang, M. Mathews, S. Haughey, S. Richards, J. Anjo, D. Zante, R. Perry |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2022-06-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933822014286/type/journal_article |
Similar Items
-
Esketamine versus placebo on time to remission in major depressive disorder with acute suicidality
by: Dong-Jing Fu, et al.
Published: (2023-08-01) -
Short-term cognitive effects of repeated-dose esketamine in adolescents with major depressive disorder and suicidal ideation: a randomized controlled trial
by: Xiaofeng Lan, et al.
Published: (2023-09-01) -
Academic Procrastination, Depressive Symptoms and Suicidal Ideation in University Students: A look during the Pandemic
by: Julio Cjuno, et al.
Published: (2022-12-01) -
Suicide‐specific mortality among patients with treatment‐resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major depressive disorder alone
by: David M. Kern, et al.
Published: (2023-08-01) -
Tinnitus, Suicide, and Suicidal Ideation: A Scoping Review of Primary Research
by: Carol MacDonald, et al.
Published: (2023-10-01)